Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1980 Nov;35(11):801–806. doi: 10.1136/thx.35.11.801

Immunological abnormalities in cystic fibrosis: chicken or egg?

M E Hodson
PMCID: PMC471387  PMID: 7013149

Full text

PDF
801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan J. D., Moss A. D., Wallwork J. C., McFarlane H. Immediate hypersensitivity in patients with cystic fibrosis. Clin Allergy. 1975 Sep;5(3):255–261. doi: 10.1111/j.1365-2222.1975.tb01860.x. [DOI] [PubMed] [Google Scholar]
  2. Assem E. S., Turner-Warwick M. Cytophilic antibodies in bronchopulmonary aspergilloma and cryptogenic pulmonary eosinophilia. Clin Exp Immunol. 1976 Oct;26(1):67–77. [PMC free article] [PubMed] [Google Scholar]
  3. Besley G. T., Patrick A. D., Norman A. P. Inhibition of the motility of gill cilia of Dreissensia by plasma of cystic fibrosis patients and their parents. J Med Genet. 1969 Sep;6(3):278–280. doi: 10.1136/jmg.6.3.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biggar W. D., Holmes B., Good R. A. Opsonic defect in patients with cystic fibrosis of the pancreas. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1716–1719. doi: 10.1073/pnas.68.8.1716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bowman B. H., Lockhart L. H., McCombs M. L. Oyster ciliary inhibition by cystic fibrosis factor. Science. 1969 Apr 18;164(3877):325–326. doi: 10.1126/science.164.3877.325. [DOI] [PubMed] [Google Scholar]
  6. Boxerbaum B., Kagumba A., Matthews L. W. Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum. Am Rev Respir Dis. 1973 Oct;108(4):777–783. doi: 10.1164/arrd.1973.108.4.777. [DOI] [PubMed] [Google Scholar]
  7. Buescher E. S., Winkelstein J. A. The ability of bacteria to activate the terminal complement components in serum of patients with cystic fibrosis. J Pediatr. 1978 Sep;93(3):530–531. doi: 10.1016/s0022-3476(78)81189-5. [DOI] [PubMed] [Google Scholar]
  8. Böhme B. Phagozytosedefekt der Granulozyten bei zystischer Fibrose. Helv Paediatr Acta. 1972 Dec;27(6):607–612. [PubMed] [Google Scholar]
  9. Böhme B. Untersuchungen zur zellulären Abwehr gegen Pseudomonas aeruginosa bei Mukoviszidose. Z Erkr Atmungsorgane. 1975 Apr;143(1):66–69. [PubMed] [Google Scholar]
  10. Collins-Williams C., Tkachyk S. J., Generoso L., Moscarello M., Toft B. Quantitative immunoglobulin levels (IgG, IgA and IgM) in children with intractable asthma. Ann Allergy. 1967 Apr;25(4):177–182. [PubMed] [Google Scholar]
  11. Conover J. H., Conod E. J., Hirschhorn K. Letter: Complement components in cystic fibrosis. Lancet. 1973 Dec 29;2(7844):1501–1501. doi: 10.1016/s0140-6736(73)92768-2. [DOI] [PubMed] [Google Scholar]
  12. Conover J. H., Conod E. J., Hirschhorn K. Studies on ciliary dyskinesia factor in cystic fibrosis. IV. Its possible identification as anaphylatoxin (C3a)-IgG complex. Life Sci. 1974 Jan 16;14(2):253–266. doi: 10.1016/0024-3205(74)90055-1. [DOI] [PubMed] [Google Scholar]
  13. Counahan R., Mearns M. B. Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis. Arch Dis Child. 1975 Jun;50(6):477–481. doi: 10.1136/adc.50.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Danes B. S., Litwin S. D., Hütteroth T. H., Cleve H., Bearn A. G. Characterization of cystic fibrosis factor and its interaction with human immunoglobulin. J Exp Med. 1973 Jun 1;137(6):1538–1543. doi: 10.1084/jem.137.6.1538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Falchuk Z. M., Taussig L. M. IgA synthesis by jejunal biopsies from patients with cystic fibrosis and hereditary pancreatitis. Pediatrics. 1973 Jan;51(1):49–54. [PubMed] [Google Scholar]
  16. GREEN M. N., KULCZYCKI L. L., SHWACHMAN H. Serum protein paper electrophoresis in patients with cystic fibrosis. Am J Dis Child. 1960 Sep;100:365–372. doi: 10.1001/archpedi.1960.04020040367009. [DOI] [PubMed] [Google Scholar]
  17. Gibbons A., Allan J. D., Holzel A., McFarlane H. Cell-mediated immunity in patients with cystic fibrosis. Br Med J. 1976 Jan 17;1(6002):120–122. doi: 10.1136/bmj.1.6002.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gugler E., Pallavicini J. C., Swedlow H., Zipkin I., Agnese P. A. Immunological studies of submaxillary saliva from patients with cystic fibrosis and from normal children. J Pediatr. 1968 Oct;73(4):548–559. doi: 10.1016/s0022-3476(68)80270-7. [DOI] [PubMed] [Google Scholar]
  19. Götz M., Lubec G. Complement in cystic fibrosis. Eur J Pediatr. 1978 Jan 17;127(2):133–139. doi: 10.1007/BF00445769. [DOI] [PubMed] [Google Scholar]
  20. Habboushe C., Iacocca V., Braddock L., Barbero G. Pseudomonas agglutinins in patients with cystic fibrosis. Pediatrics. 1971 Dec;48(6):973–974. [PubMed] [Google Scholar]
  21. Hann S., Holsclaw D. S., Shin H. S. Letter: Complement components in cystic fibrosis. Lancet. 1974 Aug 31;2(7879):520–521. doi: 10.1016/s0140-6736(74)92044-3. [DOI] [PubMed] [Google Scholar]
  22. Hoiby N., Mathiesen L. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):559–566. [PubMed] [Google Scholar]
  23. Holby N., Olling S. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases. Acta Pathol Microbiol Scand C. 1977 Apr;85(2):107–114. [PubMed] [Google Scholar]
  24. Høiby N., Hertz J. B. Precipitating antibodies against E. coli, B. fragilis, and P. aeruginosa in CF patients and normal persons determined by means of crossed immunoelectrophoresis. Monogr Paediatr. 1979;10:138–143. [PubMed] [Google Scholar]
  25. KULCZYCKI L. L., MUELLER H., SHWACHMAN H. Respiratory allergy in patients with cystic fibrosis. JAMA. 1961 Feb 4;175:358–364. doi: 10.1001/jama.1961.03040050014004. [DOI] [PubMed] [Google Scholar]
  26. Lieberman J. Carboxypeptidase B-like activity and C3 in cystic fibrosis. Am Rev Respir Dis. 1975 Jan;111(1):100–102. doi: 10.1164/arrd.1975.111.1.100. [DOI] [PubMed] [Google Scholar]
  27. Lieberman J., Kaneshiro W. Abnormal response of cultured lymphocytes to phytohemagglutinin and autologous serum in cystic fibrosis. Am Rev Respir Dis. 1977 Dec;116(6):1047–1055. doi: 10.1164/arrd.1977.116.6.1047. [DOI] [PubMed] [Google Scholar]
  28. Lyrene R. K., Polhill R. B., Jr, Guthrie L. A., Tiller R. E. Alternative complement pathway activity in cystic fibrosis. J Pediatr. 1977 Oct;91(4):681–682. doi: 10.1016/s0022-3476(77)80536-2. [DOI] [PubMed] [Google Scholar]
  29. MURRAY M. J., THAL A. P. The clinical significance of circulating pancreatic antibodies. Ann Intern Med. 1960 Sep;53:548–555. doi: 10.7326/0003-4819-53-3-548. [DOI] [PubMed] [Google Scholar]
  30. Marcer V., Mastella G., Mengoli V. Immunoglobuline nel siero, nell'escreato e nella saliva di pazienti affetti da fibrosi cistica (mucoviscidosi) con mportanti complicanze respiratorie. Riv Clin Pediatr. 1970 Sep-Oct;83(3):135–143. [PubMed] [Google Scholar]
  31. Marchi A. G., Marchi M. A., Mastella G., Nordio S. Abnormal beta-glucuronidase activity in cystic fibrosis. Helv Paediatr Acta. 1973 Nov;28(5):427–435. [PubMed] [Google Scholar]
  32. Martinez-Tello F. J., Braun D. G., Blanc W. A. Immunoglobulin production in bronchial mucosa and bronchial lymph nodes, particularly in cystic fibrosis of the pancreas. J Immunol. 1968 Nov;101(5):989–1003. [PubMed] [Google Scholar]
  33. Matthews W. J., Jr, Williams M., Oliphint B., Geha R., Colten H. R. Hypogammaglobulinemia in patients with cystic fibrosis. N Engl J Med. 1980 Jan 31;302(5):245–249. doi: 10.1056/NEJM198001313020501. [DOI] [PubMed] [Google Scholar]
  34. May J. R., Herrick N. C., Thompson D. Bacterial infection in cystic fibrosis. Arch Dis Child. 1972 Dec;47(256):908–913. doi: 10.1136/adc.47.256.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McCarthy D. S., Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy. 1971 Dec;1(4):415–432. doi: 10.1111/j.1365-2222.1971.tb00793.x. [DOI] [PubMed] [Google Scholar]
  36. McFarlane H., Allan J. D., van der Zeil P. Passive cutaneous anaphylaxis (PCA) and specific IgE in cystic fibrosis and their heterozygotes. Clin Allergy. 1977 May;7(3):279–284. doi: 10.1111/j.1365-2222.1977.tb01453.x. [DOI] [PubMed] [Google Scholar]
  37. McFarlane H., Holzel A., Brenchley P., Allan J. D., Wallwork J. C., Singer B. E., Worsley B. Immune complexes in cystic fibrosis. Br Med J. 1975 Feb 22;1(5955):423–428. doi: 10.1136/bmj.1.5955.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mearns M., Longbottom J., Batten J. Precipitating antibodies to aspergillus fumigatus in cystic fibrosis. Lancet. 1967 Mar 11;1(7489):538–539. doi: 10.1016/s0140-6736(67)92115-0. [DOI] [PubMed] [Google Scholar]
  39. Mitchell-Heggs P., Mearns M., Batten J. C. Cystic fibrosis in adolescents and adults. Q J Med. 1976 Jul;45(179):479–504. [PubMed] [Google Scholar]
  40. Nelson L. A., Callerame M. L., Schwartz R. H. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis. 1979 Oct;120(4):863–873. doi: 10.1164/arrd.1979.120.4.863. [DOI] [PubMed] [Google Scholar]
  41. Rachelefsky G. S., Osher A., Dooley R. E., Ank B., Stiehm E. R. Coexistent respiratory allergy and cystic fibrosis. Am J Dis Child. 1974 Sep;128(3):355–359. doi: 10.1001/archpedi.1974.02110280085010. [DOI] [PubMed] [Google Scholar]
  42. STEIN A. A., MANLAPAS F. C., SOIKE K. F., PATTERSON P. R. SPECIFIC ISOANTIBODIES IN CYSTIC FIBROSIS. A STUDY OF SERUM AND BRONCHIAL MUCUS. J Pediatr. 1964 Oct;65:495–500. doi: 10.1016/s0022-3476(64)80285-7. [DOI] [PubMed] [Google Scholar]
  43. Salvaggio J. E., Waldman R. H., Fruchtman M. H., Wigley F. M., Johnson J. E., 3rd Systemic and secretory antibody response of atopic and non-atopic individuals in intranasally administered tetanus toxoid. Clin Allergy. 1973 Mar;3(1):43–49. doi: 10.1111/j.1365-2222.1973.tb01308.x. [DOI] [PubMed] [Google Scholar]
  44. Scanlin T. F., Jr, Norman M. E., Rosenlund M. L. Letter: C3 in cystic fibrosis. Lancet. 1975 Jun 21;1(7921):1382–1382. doi: 10.1016/s0140-6736(75)92294-1. [DOI] [PubMed] [Google Scholar]
  45. Schiotz P. O., Hoiby N., Juhl F., Permin H., Nielsen H., Svehag S. E. Immune complexes in cystic fibrosis. Acta Pathol Microbiol Scand C. 1977 Feb;85(1):57–64. doi: 10.1111/j.1699-0463.1977.tb03611.x. [DOI] [PubMed] [Google Scholar]
  46. Schiøtz P. O., Nielsen H., Høiby N., Glikmann G., Svehag S. E. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection. Acta Pathol Microbiol Scand C. 1978 Feb;86(1):37–40. doi: 10.1111/j.1699-0463.1978.tb02555.x. [DOI] [PubMed] [Google Scholar]
  47. Schwartz R. H. Serum immunoglobulin levels in cystic fibrosis. Am J Dis Child. 1966 Apr;111(4):408–411. doi: 10.1001/archpedi.1966.02090070106015. [DOI] [PubMed] [Google Scholar]
  48. Shwachman H., Kowalski M., Khaw K. T. Cystic fibrosis: a new outlook. 70 patients above 25 years of age. Medicine (Baltimore) 1977 Mar;56(2):129–149. [PubMed] [Google Scholar]
  49. Sorensen R. U., Stern R. C., Polmar S. H. Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs. J Pediatr. 1978 Aug;93(2):201–205. doi: 10.1016/s0022-3476(78)80496-x. [DOI] [PubMed] [Google Scholar]
  50. South M. A., Warwick W. J., Wolheim F. A., Good R. A. The IgA system. 3. IgA levels in the serum and saliva of pediatric patients--evidence for a local immunological system. J Pediatr. 1967 Nov;71(5):645–653. doi: 10.1016/s0022-3476(67)80199-9. [DOI] [PubMed] [Google Scholar]
  51. Taylor B., Norman A. P., Orgel H. A., Stokes C. R., Turner M. W., Soothill J. F. Transient IgA deficiency and pathogenesis of infantile atopy. Lancet. 1973 Jul 21;2(7821):111–113. doi: 10.1016/s0140-6736(73)93060-2. [DOI] [PubMed] [Google Scholar]
  52. VAN METRE T. E., Jr, COOKE R. E., GIBSON L. E., WINKENWERDER W. L. Evidence of allergy in patients with cystic fibrosis of the pancreas. J Allergy. 1960 Mar-Apr;31:141–150. doi: 10.1016/0021-8707(60)90037-x. [DOI] [PubMed] [Google Scholar]
  53. Wallwork J. C., Brenchley P., McCarthy J., Allan J. D., Moss D., Ward A. M., Holzel A., Williams R. F., McFarlane H. Some aspects of immunity in patients with cystic fibrosis. Clin Exp Immunol. 1974 Nov;18(3):303–320. [PMC free article] [PubMed] [Google Scholar]
  54. Wallwork J. C., McFarlane H. The SIgA system and hypersensitivity in patients with cystic fibrosis. Clin Allergy. 1976 Jul;6(4):349–358. doi: 10.1111/j.1365-2222.1976.tb01915.x. [DOI] [PubMed] [Google Scholar]
  55. Warner J. O., Norman A. P., Soothill J. F. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet. 1976 May 8;1(7967):990–991. doi: 10.1016/s0140-6736(76)91862-6. [DOI] [PubMed] [Google Scholar]
  56. Warner J. O., Taylor B. W., Norman A. P., Soothill J. F. Association of cystic fibrosis with allergy. Arch Dis Child. 1976 Jul;51(7):507–511. doi: 10.1136/adc.51.7.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Warren C. P., Tai E., Batten J. C., Hutchcroft B. J., Pepys J. Cystic fibrosis--immunological reactions to A. fumigatus and common allergens. Clin Allergy. 1975 Mar;5(1):1–12. doi: 10.1111/j.1365-2222.1975.tb01831.x. [DOI] [PubMed] [Google Scholar]
  58. Wood R. E., Boat T. F., Doershuk C. F. Cystic fibrosis. Am Rev Respir Dis. 1976 Jun;113(6):833–878. doi: 10.1164/arrd.1976.113.6.833. [DOI] [PubMed] [Google Scholar]
  59. Yohe R. M. Allergy in patients with cystic fibrosis. Ann Allergy. 1972 Nov;30(11):627–631. [PubMed] [Google Scholar]
  60. di Sant'agnese P. A., Davis P. B. Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med. 1979 Jan;66(1):121–132. doi: 10.1016/0002-9343(79)90491-1. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES